Tiwari H, Kumar A, Kulkarni S K
University Institution of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India.
Singapore Med J. 2004 Mar;45(3):117-20.
The present pilot study was conducted in order to establish the drug-prescribing trend of anti-hypertensive agents at the Panjab University Health Centre in India.
A pilot study of six-month duration was conducted at the Panjab University Health Centre. The information was collected from the patients attending the outpatient department through a random sample method. World Health Organisation-based prescription-auditing proforma was used for data collection.
This study revealed that most of the male patients were on monotherapy (60 percent). In the monotherapy category, four classes of drugs were used. These were calcium channel blockers (48.1 percent), beta-blockers (46.2 percent), ACE inhibitors (3.9 percent) and diuretics (1.9 percent). Among monotherapy drugs, calcium channel blockers were prescribed most whereas diuretics were least used. Among those who were treated with drug combinations, 92.1% received two drugs and 7.9 percent received three drugs. In combination therapy, a two-drug combination consisting of beta-blockers and calcium channel blockers was given to the majority of the patients. Overall, 57.8 percent patients were treated with a single anti-hypertensive drug and 42.2 percent were treated with anti-hypertensive drug combinations.
The present study represents the current prescribing trend for anti-hypertensive agents and it highlights certain shortcomings in the existing prescribing practice. There is a considerable scope for improvement, particularly the under-utilisation of diuretics in the present prescribing pattern of anti-hypertensive drugs.
开展本试点研究是为了确定印度旁遮普大学健康中心抗高血压药物的处方趋势。
在旁遮普大学健康中心进行了为期六个月的试点研究。通过随机抽样方法从门诊部就诊的患者中收集信息。使用基于世界卫生组织的处方审核表格进行数据收集。
本研究显示,大多数男性患者采用单一疗法(60%)。在单一疗法类别中,使用了四类药物。这些药物分别是钙通道阻滞剂(48.1%)、β受体阻滞剂(46.2%)、血管紧张素转换酶抑制剂(3.9%)和利尿剂(1.9%)。在单一疗法药物中,钙通道阻滞剂的处方量最大,而利尿剂的使用量最少。在接受联合用药治疗的患者中,92.1%接受了两种药物治疗,7.9%接受了三种药物治疗。在联合治疗中,大多数患者接受了由β受体阻滞剂和钙通道阻滞剂组成的两种药物联合治疗。总体而言,57.8%的患者接受了单一抗高血压药物治疗,42.2%的患者接受了抗高血压药物联合治疗。
本研究代表了当前抗高血压药物的处方趋势,并突出了现有处方实践中的某些不足之处。有相当大的改进空间,特别是在目前抗高血压药物的处方模式中利尿剂的使用不足。